SAMRAT PHARMACHEM LTD.-has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/02/2024 ,inter alia, to consider and approve Pursuant to Regulation 29(2) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, notice is hereby given that a meeting of the Board of Directors of the Company will be held at 03:00 P.M. on Wednesday, the 14th day of February, 2024 at the Corporate Office of the Company at 701/702, Business Square, M. A. Road, Andheri (West), Mumbai - 400 058, inter alia, to consider and take on record the Un-Audited Financial Results of the Company under Indian Accounting Standards (Ind-As) for the quarter ended December 31, 2023. The Company shall intimate to the exchanges the Un-Audited financial results upon the conclusion of the aforesaid Board Meeting and will arrange for the announcement of the same in the Press and on the company's, website as required under the Listing Agreement.